Clinical Trial Update: Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial of rituximab in young patients receiving chemotherapy for B-cell non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University Hospital Erlangen | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED